Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
This study has been completed.
First Posted: May 13, 2008
Last Update Posted: April 9, 2015
Eli Lilly and Company
Information provided by (Responsible Party):